Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-2 of 2

Sort by

Sort Order Select

Journal Articles

Phase 1/2 Study of Nexi-001 Donor-Derived Multi-Antigen Specific CD8+ T Cells for the Treatment of Relapsed Acute Myeloid Leukemia (AML) after Allogeneic Hematopoietic Transplantation

Monzr M. Al Malki, Sumithira Vasu, Dipenkumar Modi, Miguel-Angel Perales, Lucy Y Ghoda, Donna Bui, Vineetha Edavana, Emily Lu, Sojung Kim, Lauren Suarez, Mathias Oelke, Daniel Bednarik, Robert D Knight, Juan C. Varela

Blood (2021) 138 (Supplement 1): 4819.

https://doi.org/10.1182/blood-2021-152419

Published: 2021

Journal Articles

Preliminary Results of the First-in-Human Study of Nexi-001, a Multi-Antigen Specific CD8+ T Cell Product, in Acute Myeloid Leukemia (AML) Patients with Relapsed Disease after Allogeneic Hematopoietic Cell Transplantation (Allo-HSCT) Demonstrate Early Signs of Safety, Tolerability and Robust Immune Responses

Monzr M. Al Malki, MD, Miguel-Angel Perales, MD, Dipenkumar Modi, MD, Sumithira Vasu, MDMBBS, Megan Nelson, RN, Donna Bui, Sojung Kim, Ruipeng Wang, Emily Lu, Mathias Oelke, Han Myint, MDFRCPath,FRCP, Juan C. Varela, MDPhD

Blood (2020) 136 (Supplement 1): 31–33.

https://doi.org/10.1182/blood-2020-139342

Published: 2020